ABEO

Abeona Therapeutics Inc.

4.54 USD
-0.04 (-0.87%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Abeona Therapeutics Inc. stock is up 8.87% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 9 June’s closed higher than May. In the last 1 Unusual Options Trades, there were 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
23 Apr 14:07 17 May, 2024 5.00 PUT 241 30

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc. develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A.